tiprankstipranks
Awakn Life Sciences (TSE:AWKN)
:AWKN
Canadian Market

Awakn Life Sciences (AWKN) Financial Statements

Compare
3 Followers

Awakn Life Sciences Financial Overview

Awakn Life Sciences's market cap is currently $3.96M. The company's EPS TTM is C$-0.061; its P/E ratio is ―; Awakn Life Sciences is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Jan 23Jan 22May 21
Income Statement
Total Revenue
Gross Profit$ 87.37K$ -1.55M$ 236.04K-
Operating Income$ -3.93M$ -9.19M$ -10.96M$ -19.34K
EBITDA$ -3.65M$ -8.78M$ -15.61M$ -19.34K
Net Income$ -5.01M$ -9.14M$ -15.47M$ -19.34K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 543.35K$ 4.39M$ 6.88M-
Total Debt$ 0.00$ 2.30M$ 1.81M$ 0.00
Net Debt$ -407.30K$ 1.74M$ 185.68K$ 0.00
Total Liabilities$ 2.07M$ 4.44M$ 3.85M$ 36.55K
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -2.38M$ -7.46M$ -10.29M-
Operating Cash Flow$ -2.38M$ -7.36M$ -8.59M-
Investing Cash Flow
Financing Cash Flow
Currency in USD

Awakn Life Sciences Earnings and Revenue History

Awakn Life Sciences Debt to Assets

Awakn Life Sciences Cash Flow

Awakn Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis